Low-dose salinomycin induces anti-leukemic responses in AML and MLL

Development of anti-cancer drugs towards clinical application is costly and inefficient. Large screens of drugs, efficacious for non-cancer disease, are currently being used to identify candidates for repurposing based on their anti-cancer properties. Here, we show that low-dose salinomycin, a cocci...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Roulston, Gary D.R., Burt, Charlotte L., Kettyle, Laura M.J., Matchett, Kyle B., Keenan, Heather L., Mulgrew, Nuala M., Ramsey, Joanne M., Dougan, Caoifa, McKiernan, John, Grishagin, Ivan V., Mills, Ken I., Thompson, Alexander
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2016
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5341990/
https://ncbi.nlm.nih.gov/pubmed/27612428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11866
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi